Literature DB >> 15067307

Multiple sclerosis.

David A Hafler1.   

Abstract

Multiple sclerosis is a complex genetic disease associated with inflammation in the CNS white matter thought to be mediated by autoreactive T cells. Clonal expansion of B cells, their antibody products, and T cells, hallmarks of inflammation in the CNS, are found in MS. This review discusses new methods to define the molecular pathology of human disease with high-throughput examination of germline DNA haplotypes, RNA expression, and protein structures that will allow the generation of a new series of hypotheses that can be tested to develop better understanding of and therapies for this disease.

Entities:  

Mesh:

Year:  2004        PMID: 15067307      PMCID: PMC362131          DOI: 10.1172/JCI21357

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  92 in total

1.  The distinction blurs between an autoimmune versus microbial hypothesis in multiple sclerosis.

Authors:  D A Hafler
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

Review 2.  An array of sunshine in multiple sclerosis.

Authors:  David A Dyment; George C Ebers
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

3.  A full genome search in multiple sclerosis.

Authors:  G C Ebers; K Kukay; D E Bulman; A D Sadovnick; G Rice; C Anderson; H Armstrong; K Cousin; R B Bell; W Hader; D W Paty; S Hashimoto; J Oger; P Duquette; S Warren; T Gray; P O'Connor; A Nath; A Auty; L Metz; G Francis; J E Paulseth; T J Murray; W Pryse-Phillips; R Nelson; M Freedman; D Brunet; J P Bouchard; D Hinds; N Risch
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

4.  Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.

Authors:  A E Lovett-Racke; J L Trotter; J Lauber; P J Perrin; C H June; M K Racke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

5.  Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.

Authors:  M J Hohol; M J Olek; E J Orav; L Stazzone; D A Hafler; S J Khoury; D M Dawson; H L Weiner
Journal:  Mult Scler       Date:  1999-12       Impact factor: 6.312

6.  Characterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients.

Authors:  Y Qin; D Q Zhang; A Prat; S Pouly; J Antel
Journal:  J Neuroimmunol       Date:  2000-08-01       Impact factor: 3.478

7.  Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein.

Authors:  S Brocke; K Gijbels; M Allegretta; I Ferber; C Piercy; T Blankenstein; R Martin; U Utz; N Karin; D Mitchell; T Veromaa; A Waisman; A Gaur; P Conlon; N Ling; P J Fairchild; D C Wraith; A O'Garra; C G Fathman; L Steinman
Journal:  Nature       Date:  1996-01-25       Impact factor: 49.962

8.  Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes".

Authors:  M Filippi; M Rovaris; M A Rocca; M P Sormani; J S Wolinsky; G Comi
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

9.  Risks of multiple sclerosis in relatives of patients in Flanders, Belgium.

Authors:  H Carton; R Vlietinck; J Debruyne; J De Keyser; M B D'Hooghe; R Loos; R Medaer; L Truyen; I M Yee; A D Sadovnick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

10.  Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions.

Authors:  S L Hauser; A K Bhan; F Gilles; M Kemp; C Kerr; H L Weiner
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

View more
  117 in total

1.  Morphological and functional characterization of leech circulating blood cells: role in immunity and neural repair.

Authors:  Céline Boidin-Wichlacz; David Vergote; Christian Slomianny; Nathalie Jouy; Michel Salzet; Aurélie Tasiemski
Journal:  Cell Mol Life Sci       Date:  2011-12-11       Impact factor: 9.261

2.  MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination.

Authors:  Marcin P Mycko; Maria Cichalewska; Agnieszka Machlanska; Hanna Cwiklinska; Magdalena Mariasiewicz; Krzysztof W Selmaj
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-18       Impact factor: 11.205

Review 3.  Multiple sclerosis.

Authors:  Alyssa Nylander; David A Hafler
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 4.  Janus head: the dual role of HLA-G in CNS immunity.

Authors:  Yu-Hwa Huang; Laura Airas; Nicholas Schwab; Heinz Wiendl
Journal:  Cell Mol Life Sci       Date:  2010-11-18       Impact factor: 9.261

Review 5.  Should we inhibit type I interferons in sepsis?

Authors:  Tina Mahieu; Claude Libert
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

6.  The role of the CD58 locus in multiple sclerosis.

Authors:  Philip L De Jager; Clare Baecher-Allan; Lisa M Maier; Ariel T Arthur; Linda Ottoboni; Lisa Barcellos; Jacob L McCauley; Stephen Sawcer; An Goris; Janna Saarela; Roman Yelensky; Alkes Price; Virpi Leppa; Nick Patterson; Paul I W de Bakker; Dong Tran; Cristin Aubin; Susan Pobywajlo; Elizabeth Rossin; Xinli Hu; Charles W Ashley; Edwin Choy; John D Rioux; Margaret A Pericak-Vance; Adrian Ivinson; David R Booth; Graeme J Stewart; Aarno Palotie; Leena Peltonen; Bénédicte Dubois; Jonathan L Haines; Howard L Weiner; Alastair Compston; Stephen L Hauser; Mark J Daly; David Reich; Jorge R Oksenberg; David A Hafler
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-23       Impact factor: 11.205

Review 7.  Target identification and validation in systemic autoimmunity.

Authors:  Stanford L Peng
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

8.  Adenosine deaminase and 5'nucleotidase activities in peripheral blood T cells of multiple sclerosis patients.

Authors:  S Vivekanandhan; C C Soundararajan; M Tripathi; M C Maheshwari
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

9.  Lithium prevents and ameliorates experimental autoimmune encephalomyelitis.

Authors:  Patrizia De Sarno; Robert C Axtell; Chander Raman; Kevin A Roth; Dario R Alessi; Richard S Jope
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  Impact of a Demyelination-Inducing Central Nervous System Virus on Expression of Demyelination Genes in Type 2 Lymphoid Cells.

Authors:  Satoshi Hirose; Mihoko Kato; Kati Tormanen; Pedram Shafiei Jahani; Omid Akbari; Homayon Ghiasi
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.